Folgen
MATTHEW HILLER
MATTHEW HILLER
Associate Professor of Criminal Justice, Temple University
Bestätigte E-Mail-Adresse bei temple.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS).
DD Simpson, GW Joe, KM Broome, ML Hiller, K Knight, GA Rowan-Szal
Psychology of Addictive Behaviors 11 (4), 279, 1997
1091*1997
Prison‐based substance abuse treatment, residential aftercare and recidivism
ML Hiller, K Knight, DD Simpson
Addiction 94 (6), 833-842, 1999
3781999
Three-year reincarceration outcomes for in-prison therapeutic community treatment in Texas
K Knight, DD Simpson, ML Hiller
The Prison Journal 79 (3), 337-351, 1999
3241999
Motivation as a predictor of therapeutic engagement in mandated residential substance abuse treatment
ML Hiller, K Knight, C Leukefeld, DD Simpson
Criminal Justice and Behavior 29 (1), 56-75, 2002
2782002
Treating substance use disorders in the criminal justice system
S Belenko, M Hiller, L Hamilton
Current psychiatry reports 15, 1-11, 2013
2422013
Predicting recidivism for released state prison offenders: Examining the influence of individual and neighborhood characteristics and spatial contagion on the likelihood of …
GJ Stahler, J Mennis, S Belenko, WN Welsh, ML Hiller, G Zajac
Criminal justice and behavior 40 (6), 690-711, 2013
2132013
Gender differences at admission and follow-up in a sample of methadone maintenance clients
LR Chatham, ML Hiller, GA Rowan-Szal, GW Joe, DD Simpson
Substance use & misuse 34 (8), 1137-1165, 1999
2091999
Risk factors that predict dropout from corrections-based treatment for drug abuse
ML Hiller, K Knight, DD Simpson
The Prison Journal 79 (4), 411-430, 1999
2001999
Legal pressure and treatment retention in a national sample of long-term residential programs
ML Hiller, K Knight, KM Broome, DD Simpson
Criminal Justice and Behavior 25 (4), 463-481, 1998
1951998
Legal pressure, treatment readiness, and engagement in long-term residential programs
K Knight, ML Hiller, KM Broome, DD Simpson
Journal of Offender Rehabilitation 31 (1-2), 101-115, 2000
1692000
Drug treatment process indicators for probationers and prediction of recidivism
KM Broome, K Knight, ML Hiller, DD Simpson
Journal of Substance Abuse Treatment 13 (6), 487-491, 1996
1631996
Peer, family, and motivational influences on drug treatment process and recidivism for probationers
KM Broome, DK Knight, K Knight, ML Hiller, DD Simpson
Journal of Clinical Psychology 53 (4), 387-397, 1997
1551997
Screening and referral for substance-abuse treatment in the criminal justice system
K Knight, DD Simpson, ML Hiller, C Leukefeld, F Tims, D Farabee
Treatment of drug offenders: Policies and issues, 259-272, 2002
1332002
A cost-effectiveness analysis of in-prison therapeutic community treatment and risk classification
JD Griffith, ML Hiller, K Knight, DD Simpson
The Prison Journal 79 (3), 352-368, 1999
1291999
Problem severity and motivation for treatment in incarcerated substance abusers
ML Hiller, E Narevic, JM Webster, P Rosen, M Staton, C Leukefeld, ...
Substance Use & Misuse 44 (1), 28-41, 2009
1032009
A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi …
JE Becan, JP Bartkowski, DK Knight, TRA Wiley, R DiClemente, ...
Health & justice 6, 1-14, 2018
942018
Treatment motivation and therapeutic engagement in prison-based substance use treatment
PJ Rosen, ML Hiller, JM Webster, M Staton, C Leukefeld
Journal of psychoactive drugs 36 (3), 387-396, 2004
902004
Recidivism following mandated residential substance abuse treatment for felony probationers
ML Hiller, K Knight, DD Simpson
The Prison Journal 86 (2), 230-241, 2006
832006
Substance abuse among rural and very rural drug users at treatment entry
ML Schoeneberger, CG Leukefeld, ML Hiller, T Godlaski
The American Journal of Drug and Alcohol Abuse 32 (1), 87-110, 2006
812006
Head injury among drug abusers: an indicator of co-occurring problems
R Walker, M Hiller, M Staton, CG Leukefeld
Journal of Psychoactive Drugs 35 (3), 343-353, 2003
732003
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20